Schiff Nutrition (NYSE: WNI) was downgraded by equities researchers at DA Davidson from a “buy” rating to a “neutral” rating in a report issued on Friday. They currently have a $16.00 target price on the stock, down from their previous target price of $18.00.
Shares of Schiff Nutrition traded down 2.04% during mid-day trading on Friday, hitting $16.506. Schiff Nutrition has a 52 week low of $8.68 and a 52 week high of $16.43. The company has a market cap of $483.1 million and a P/E ratio of 33.70.
Schiff Nutrition last announced its earnings results on Thursday, March 22nd. The company reported $0.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.04. The company’s revenue for the quarter was up 25.1% on a year-over-year basis. On average, analysts predict that Schiff Nutrition will post $0.13 earnings per share next quarter.
WNI has been the subject of a number of other recent research reports. Analysts at Sidoti downgraded shares of Schiff Nutrition from a “buy” rating to a “neutral” rating in a research note to investors on Tuesday, May 1st. Finally, analysts at Imperial Capital upgraded shares of Schiff Nutrition to an “outperform” rating in a research note to investors on Monday, March 26th.
Schiff Nutrition International, Inc. develops, manufactures, markets and distributes branded and private label vitamins, nutritional supplements and nutrition bars in the United States and throughout the world.